期刊文献+

对1例重症肺炎伴肾功能衰竭患者的药学监护 被引量:3

Pharmaceutical care on a patient with severe pneumonia and renal failure
暂未订购
导出
摘要 1例87a男性患者,因重症肺炎伴呼吸衰竭、休克、肾功能衰竭入ICU,先后予以莫西沙星、头孢哌酮舒巴坦联合万古霉素和卡泊芬净抗感染,多巴胺升压、氢化可的松抗休克以及肠外营养等治疗。该患者有糖尿病史,在肠外营养支持过程中,对患者血糖情况进行监测;根据患者肝肾功能情况,及时调整抗菌药物剂量,并对莫西沙星致神经系统不良反应进行监测。治疗期间,临床药师在药物剂量调整,营养状况评估,潜在的药物不良反应,生命体征监测特别是肝肾功能情况等方面提供了全面及时的药学服务。 An 87-year-old male patient with severe pneumonia accompanied with respiratory failure,shock and renal failure was hospitalized in ICU.The patient was treated with combination use of moxifloxacin,cefoperazone and sulbactam,vancomycin and caspofungin for anti-infection,dopamine for boosting pressure,hydrocortisone for septic shock and parenteral nutrition therapy.The patient had the history of diabetes,the blood sugar levels were monitored during the therapy of nutritional support;the dose of antibacterials were adjusted timely according to liver and kidney function;the nervous system adverse reaction caused by moxifloxacin was monitored.During the treatment,clinical pharmacist timely assessed the drug therapy,and provided the pharmaceutical care on the dose adjustment,nutritional status assessment,monitoring potential adverse drug reactions and the vital signs especially for liver and kidney function.
作者 赵蕊 钱云
出处 《中国药物应用与监测》 CAS 2010年第6期366-368,共3页 Chinese Journal of Drug Application and Monitoring
关键词 临床药师 药学监护 肾功能衰竭 营养 药品不良反应 Clinical pharmacist Pharmaceutical care Renal failure Nutrition Adverse drug reaction
  • 相关文献

参考文献10

二级参考文献46

  • 1徐厚明,孙骏,王越,朱学中.211例药源性急性肾功能衰竭中国期刊文献分析[J].中国新药杂志,2006,15(11):925-927. 被引量:3
  • 2戴林.药物临床信息参考[M].成都:四川科学技术出版社,2006:235-236.
  • 3Ball P. Adverse drug reactions:implications for the development of fluoroquinolones [ J ]. J Antimicrob Chemother, 2003, 51 ( Suppl 1 ) :21-27.
  • 4Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy:a clinical and evidence-based approach [ J]. Circulation, 2006 ; 113 (14) :1799- 806.
  • 5Briguori C, Airoldi F, Morici N, et al. New pharmacological protocols to prevent or reduce contrast media nephropatby[J]. Minerva Cardioangial, 2005 ;53( 1 ) :49-58.
  • 6Cavusoglu ES, Chhabra JD, Marmur A, et al. The prevention of contrast induced nephropathy in patients undergoing percutaneous coronary intervention[J]. Minerva C',n'dioangiol,2004;52(5) :419-32.
  • 7Cowbum PJ, Patel H, Pipes RR, et al. Contrast nephropathy post cardiac resynchronization therapy:an under recognized complication with important morbidity[ J]. Eur J Heart Fail,2005 ;7 ( 15 ) :899-903.
  • 8Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate:arandomized controlled trial [ J]. JAMA,2004 ;291 ( 19 ) :2328-34.
  • 9Brar SS, Shen AY, Jorgensen MB, et al. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography:a randomized trial[J]. JAMA ,2008 ;300(9 ) : 1038-46.
  • 10Perazella MA. Drug-induced renal failure: Update on new medications and unique mechanisms of nephrotoxicity [ J ]. Am J Med, 2003 ; 325 ( 1 ) :349-62.

共引文献287

同被引文献29

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部